Elbit Imaging Announces Amendment to the 2014 Restructuring

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Elbit Imaging Announces Amendment to the 2014 Restructuring Plan of Its Subsidiary, Plaza Centers

TEL AVIV, Israel, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE: EMITF ) (NASDAQ: EMITF ) announced today, in further to its announcement dated on July 21, 2014, regarding the restructuring plan approval of Plaza Centers N.V. ("Plaza") (LSE: PLAZ ), an indirect subsidiary (45%) of the Company, the following updates:

  1. Under the Restructuring Plan, principal payments under the notes (both those that are traded on the Tel Aviv Stock Exchange and those held by Polish investors) issued by Plaza and originally due in the years 2013 to 2015 were deferred for a period of four and a half years, and principal payments originally due in 2016 and 2017 were deferred for a period of one year (the “ Extended Repayment Schedule ”).
  2. The Restructuring Plan further provides that, if Plaza does not prepay an aggregate amount of at least NIS 434,000,000 (approximately €103 million) on the principal of the notes on or before 1 December 2016 (the “ Early Prepayment ”), the principal payments due under the Extended Repayment Schedule will be advanced by one year (the “ Accelerated Repayment Schedule ”).
  3. Since the Restructuring Plan became effective, Plaza has made Early Prepayments of an aggregate amount of approximately NIS 142.5 million (approximately €34 million) and has repaid a total amount of approximately €71 million on account of principal and interest (on top of the issuance to the bondholders of 13.21% of its outstanding share capital). At the same time, Plaza continues to implement an aggressive cost cutting plan in order to reduce its general and administrative expenses (such expenses were reduced by approximately 20% over the mentioned period).
  4. Plaza is currently in active negotiations on several disposal transactions with a total negotiated value of approximately €140 million (with an estimated €71 million expected net proceeds to the Company) and, although there is no certainty that the transactions will be completed, it is expected that the closing of these transactions will take place within few months after 1 December 2016.
  5. The enforcement of the Accelerated Repayment Schedule would add significant pressure to Plaza’s liquidity and result in an acceleration of the asset sales, which is likely to have an adverse impact upon the value achieved on any disposals. The Accelerated Repayment Schedule may, therefore, adversely affect the position of Plaza’s stakeholders, including its shareholders and creditors.
  6. Accordingly, Plaza has a strong preference to continue operating on the basis of the Extended Repayment Schedule. In order to ensure that the Extended Repayment Schedule remains applicable, in the event that the closing of the aforementioned transactions takes longer than anticipated, Plaza is proposing to seek, from its bondholders, a relaxation of the terms of the Early Prepayment required to maintain the Extended Repayment Schedule.
  7. The proposed amendments sought by Plaza comprise the postponement of the Early Prepayment date by up to four (4) months, and the reduction of the total amount of the required Early Prepayments to at least NIS 382,000,000 (a reduction of up to 12% from the original amount) (the “ Requested Amendment ”). Apart from this Requested Amendment, Plaza intends to fully comply with the repayment schedule of the notes. Plaza intends to implement the Requested Amendment through a consensual process with its bondholders and will shortly be initiating discussions with its bondholders in order to seek their consent to the Requested Amendment.
  8. Plaza has made considerable progress in creating value and generating proceeds from its assets and appreciates the continued support of its stakeholders in order to be able to continue the implementation of the approved Restructuring Plan.

The Company will update regarding any new developments.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii)  Hotel - operation and management of the Radisson hotel Complex in Bucharest, Romania. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Plots in India - plots designated for sale initially designated to residential projects.

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as “believe,” “expect,” “intend,” “estimate” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, a change in market conditions, a decision to deploy the cash for other business opportunities and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2015, under the caption “Risk Factors.” Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained in our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information: Company Contact Ron Hadassi Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 ron@elbitimaging.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 4

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

CoreWeave Gains Amid NVIDIA Partnership, Faces Skepticism

Updated Category News Views 205

CoreWeave Stock Surges with NVIDIA Agreement Shares of CoreWeave, Inc. experienced a notable increase recently following the announcement of a significant partnership with NVIDIA Corp. This new agreement, valued at an initial $6.3 billion, allows NVIDIA to purchase any excess cloud computing capacity that CoreWeave may have available. The partnership is expected to last...

Continue Reading
Coty's Preliminary Q1 Review: Sales Growth Insights and Strategy

Updated Category News Views 65

Coty Inc. Preliminary Q1 Overview Coty Inc. (NYSE: COTY) has recently reported its preliminary numbers for the first quarter, revealing some intriguing insights into its sales growth. The company experienced a modest increase of approximately 4%-5% on a like-for-like basis, which unfortunately fell short of their previous estimate of 6%. This slight underperformance has...

Continue Reading
Uncle Funky's Daughter Launches Innovative Hair Mousse

Updated Category News Views 420

Introducing Soul Bounce Texture Defining Mousse Uncle Funky's Daughter, a celebrated minority-owned hair care brand, has introduced an innovative product known as Soul Bounce Texture Defining Mousse. This exciting addition aims to elevate the hairstyling routine for individuals with textured hair, offering a solution that balances definition, volume, and health. The...

Continue Reading
Arconic Corporation Faces Class Action Lawsuit Over Securities Losses

Updated Category News Views 205

Arconic Corporation's Legal Challenges for Investors In the ever-evolving landscape of corporate governance, Arconic Corporation is currently facing serious legal scrutiny. Investors are being made aware that a class action lawsuit has been initiated against the company, highlighting concerns over significant losses among shareholders. Class Action Overview This lawsuit...

Continue Reading
Key Insights on Centene Corporation Class Action for Investors

Updated Category News Views 131

Understanding the Centene Corporation Class Action Lawsuit In recent developments, Centene Corporation (NYSE: CNC) has found itself at the center of a class action lawsuit. This legal proceeding has garnered attention due to allegations that Centene and its senior executives may have violated federal securities laws. Legal representation is being offered by a leading firm...

Continue Reading